
Relay Therapeutics Inc (RLAY)
NASDAQ
Fin d'année 31 Décembre 2024 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -22.764 | -18.33 | -38.595 | -40.245 | -27.56 | -35.187 | -39.377 |
Return on Equity (%) | 87.959 | 51.691 | -78.991 | -43.811 | -31.44 | -40.18 | -44.151 |
Return on Invested Capital (%) | -23.739 | -21.64 | -9.974 | -44.003 | -32.479 | -43.962 | -48.849 |
Operating Margin (%) | N/A | N/A | -63.411 | -12012.942 | -21036.133 | -1338.656 | -3374.718 |
Net Profit Margin (%) | N/A | N/A | -278.512 | -12012.942 | -21036.133 | -1338.656 | -3374.718 |
Book Value Per Share | 39.567 | 24.926 | 8.49 | 9.951 | 7.827 | 6.082 | 4.633 |
Earnings Per Share | -4.583 | -5.253 | -2.56 | -4.043 | -2.399 | -2.774 | -2.018 |
Cash Per Share | 39.597 | 2.926 | 4.979 | 3.113 | 1.253 | 1.166 | 0.743 |
Working Capital Per Share | 39.196 | 24.313 | 8.414 | 10.578 | 7.892 | 6.002 | 4.531 |
Operating Profit Per Share | N/A | N/A | 0.919 | 0.034 | 0.108 | 0.259 | 0.139 |
EBIT Per Share | -4.583 | -5.253 | -0.583 | -4.043 | -2.399 | -2.774 | -2.018 |
EBITDA Per Share | -4.583 | -5.253 | -0.583 | -4.043 | -2.399 | -2.774 | -2.018 |
Free Cash Flow Per Share | -4.627 | -4.893 | -2.578 | -4.048 | -2.358 | -2.783 | -2.038 |
Fin d'année 31 Décembre 2024 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 10,65M | 14,34M | 89,91M | 89,99M | 121,11M | N/A | N/A |
Fin d'année 31 Décembre 2024 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | -41698.673 | N/A | N/A | N/A | -813.301 | N/A | N/A | N/A |
Net Profit Margin (%) | -41698.673 | N/A | N/A | N/A | -813.301 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 418,72M |
Ratio cours/bénéfice | -1,25 |
Ratio prix/ventes | 18,26 |
Ratio prix/liquidités | 3,41 |
Ratio prix/valeur comptable | 0,54 |
Rendement de dividende | - |
Actions en circulation | 169,52M |
Volume moyen (1 semaine) | 2,54M |
Volume moyen (1 mois) | 2,63M |
Variation sur 52 semaines | -68,05% |
Plus haut sur 52 semaines | 10,72 |
Plus bas sur 52 semaines | 2,36 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales